NA Proactive news snapshot: Empower Clinics, MegumaGold, Naturally Splendid, LeanLife Health, RedHill Biopharma ...

NA Proactive news snapshot: Empower Clinics, MegumaGold, Naturally Splendid, LeanLife Health, RedHill Biopharma ...

Proactive Investors

Published

Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FRA:8EC), an integrated healthcare company, announced on Thursday the successful launch of its saliva-based COVID-19 reverse transcription PCR (KAI Saliva PCR Test), with an initial soft launch of 5,000 units sold out. The Vancouver-based company said it is now focused on an order for 25,000 additional units with a sales value of around $5.5 million. The group noted that the initial demand for KAI Saliva Tests stemmed from its existing customers in the film and television industry, the commercial sector, and concierge testing supported by its Sun Valley Health subsidiary in Arizona.  MegumaGold Corp (CSE:NSAU) (OTCMKTS:NSAUF) (FRA:2CM2) is set to purchase all of Canadian GoldCamps Corp (CSE:CAMP) (OTCMKTS:SMATF) (FRA:A681) assets in a deal, which replaces the previously announced share exchange merger agreement announced last November, which has now been terminated. The pair, on January 4, have now struck an asset purchase agreement, which sees gold explorer Canadian GoldCamps sell to MegumaGold all of its Canadian assets and associated working capital in exchange for MegumaGold shares. The latter's shares will be distributed directly to Canadian GoldCamps' shareholders, subject to a shareholder vote and other regulatory approvals. Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCQB:NSPDF) (FRA:50N) told investors that Meridian Farm Markets, the eight-store chain with three decades of history in the Greater Vancouver region, will offer customers a variety of the company's NATERA Plant Based Foods. Its retail outlets in BC include Meridian Meats butcher shops in Port Coquitlam, Langley and White Rock and the Meridian Farm Markets in Maple Ridge and Mission. "Many people living in the Greater Vancouver Area recognize the Meridian brand for their quality products and quality service, making them a perfect venue for NATERA Plant Based products," said Craig Goodwin, Naturally Splendid's CEO.  LeanLife Health Inc (CSE:LLP) (FRA:LL1) (OTCPINK:LHLNF), which is preparing to launch its Mike Tyson-branded Iron Energy drink in Canada, has submitted nine Temporary Market Authorizations (TMA) to the Canadian Food Inspection Agency. Currently, all caffeinated beverages sold in Canada require a TMA and the applications for TMA include all three flavors in all three sizes of the Iron Energy drink, according to a statement. LeanLife noted Thursday that the approval process takes many months and Gavin Mah, the company's chief operating officer, will be focused on helping navigate the regulatory approval process as quickly as possible. RedHill Biopharma Ltd (NASDAQ:RDHL) has said its drug candidate RHB-204 has been granted Fast Track designation by the US Food & Drug Administration (FDA). The specialty biopharmaceutical company said it is being developed as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium Avium Complex. NTM lung disease, is a chronic and debilitating condition caused by environmental bacteria found in soil, as well as natural and engineered water systems. There is no FDA-approved first-line therapy for this disease. The incidence and prevalence of pulmonary NTM disease are increasing in many areas of the world. There were an estimated 110,000 pulmonary NTM disease patients in the US in 2017, with US market potential estimated at over $500 million. Loop Insights Inc (CVE:MTRX) (OTCQB:RACMF) announced that it has appointed Danny Spataro as senior director of sales, sports, and entertainment. Spataro, whose new job starts January 11, brings more than 15 years of sales and marketing experience to Loop, including roles in collegiate and professional sports as well as SaaS (software as a service), according to a statement.  He spent 11 years with Learfield IMG College, highlighted by sales leadership roles serving Texas A&M, Arizona, Penn State, Northwestern, and Harvard. After that, he went to work with Fenway Sports Management, the parent company of the Boston Red Sox, Liverpool Football, and New England Sports Network. After Fenway, Spataro spent time at New Hampshire Motor Speedway (SMI), part of the NASCAR circuit. Also, Loop noted that Spataro’s last three years have been highlighted by successful tenures at technology giant Oracle Corporation (NYSE:ORCL) (FRA:ORC) and most recently SSB. Antibe Therapeutics Inc (TSE:ATE) (OTCQB:ATBPF) (FRA:4B70) is bolstering its advisory team with the appointment of biotech executive Dr Don Haut to its Partnering Advisory Team. Haut recently served as the chief business officer of AskBio, a clinical-stage developer of gene therapies and technologies. During his tenure at the company, Haut played a key role in pharmaceutical giant Bayer AG’s $4 billion acquisition of AskBio. Haut earned his PhD in molecular biology from the Medical School at the University of Missouri-Columbia and an MBA from Washington University’s Olin School of Business. Fury Gold Mines Limited (TSE:FURY) (NYSEAMERICAN:FURY) (FRA:AUN1) has named Salisha Ilyas as its first vice president of investor relations, effective immediately, the company announced after the close Thursday. Ilyas was the founder and principal consultant at Target IR & Communications, a full-service investor relations (IR) firm focused on providing advisory and communications support to junior mining companies. She brings more than 10 years of experience in the mining industry, having also worked for Canadian and international mining companies, including Petra Diamonds Ltd (LON:PDL) (FRA:FPO), Desert Lion Energy, Aura Minerals Inc (TSE:ORA) (OTCMKTS:ARMZF) and Champion Iron Mines. Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:MEDXF) (FRA:P731) announced that it has engaged Independent Trading Group (ITG), Inc. to provide market-making services to the company in accordance with TSX Venture Exchange policies. ITG will trade the company’s common shares on the TSXV and other marketplaces, as applicable, with the objective of maintaining a reasonable market and improving the liquidity of the common shares. Under the terms of a services agreement, ITG will receive compensation of C$5,000 per month (plus applicable taxes), payable on the first business day of each month, for an initial term of three months, with services commencing on January 6, 2021. The services agreement will automatically renew for additional one-month terms unless terminated by either party in accordance with the terms and conditions of the Services Agreement. The Services Agreement may be terminated by either party with 30 days’ notice. Nova Royalty Corp. (CVE:NOVR) announced that it has been approved for graduation from Tier 2 to Tier 1 issuer status on the TSX Venture Exchange effective January 8, 2021. The TSXV classifies issuers into different tiers based on certain standards including historical financial performance, stage of development and financial resources. Tier 1 is the TSXV's premier tier and is reserved for the TSXV's most advanced issuers with the most significant financial resources.  With the graduation to a Tier 1 listing on the TSXV, the securities of Nova previously deposited into escrow will now be governed by the release provisions of issuers subject to Tier 1 status and released over 18 months.  Naturally Splendid Enterprises Ltd (CVE:NSP) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on September 2, 2020, which saw the issue of 17,554,168 shares at a purchase price of 6 cents per shares, together with 8,777,084 share purchase warrants with an exercise price of 10 cents for a two-year period, subject to an acceleration clause with, 33 places. Australis Capital Inc. (CSE:AUSA) (OTCMKTS:AUSAF) has said it is hosting a conference call on January 7, 2021, at 12.00pm ET to discuss the announced intended transactions in regards Green Therapeutics and ALPS. Conference Call Participant Numbers Confirmation #: 87780553; Local: 416-764-8659; North American Toll Free: 1-888-664-6392; Webcast URL: http://bitly.ws/b23 The International Speculator, in its December 23, 2020, issue, said buy District Metals Corp. (CVE:DMX) at 35 cents, officially, Buy up to 45 cents. This is the newsletter's first buy of the stock. The writer says that not only is the company poised for a major silver discovery to capitalize on rising precious metals markets, it is also sitting on a potential "treasure trove" of critical metals like copper. That could make it a big winner as local demand from the European battery sector surges. District Metals' chief executive officer is Garrett Ainsworth, who has been involved in two major Canadian uranium stories -- fellow Casey picks NexGen Energy Ltd. and Alpha Minerals, which was taken over by Fission Uranium Corp. The outlook is promising because its project is very close to numerous operating mines for all these metals. With recent financings, the writer believes District can easily pay for upcoming drilling programs, which are still a few months away. Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF), the clinical-stage biotech company, said Thursday that its CEO David Elsley will take part in the following  virtual investor conferences in January:  The 10th Annual LifeSci Partners Corporate Access Event - January 6-8 and 11-14, 2021 - where he will present and participate in a panel discussion "Developing Drugs for Cardiovascular Indications", and hold one-on-one investor meetings; The H.C. Wainwright Bioconnect 2021 Conference - January 11-14, 2021. Elsley will give a presentation which will also be available for viewing on Cardiol's website; The Biotech Showcase 2021 - January 11-15, in which Elsley will present and hold one-on-one investor meetings; and  The ATB 9th Annual Institutional Investor Conference - January 13-14, 2021, in which he will participate in a panel discussion "Cannabinoid-derived Pharmaceuticals & Biosynthesis" and hold one-on-one investor meetings. CanaFarma Hemp Products Corp (CSE:CNFA) announced Thursday the resignations of Frank Barone and Kirill Chumenko as officers of the company. In a statement, CanaFarma said it had initiated the process of looking for the best available replacement for both of their positions. The company wishes Frank and Kirill the best in their future endeavors.

Full Article